Literature DB >> 8207616

Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix.

P Inki1, F Stenbäck, S Grenman, M Jalkanen.   

Abstract

Expression of syndecan-1, a cell surface proteoglycan that binds growth factors and extracellular matrix components, was studied in normal and pathological human uterine cervix using immunohistochemical methods. Normal cervical squamous epithelium showed positive staining for syndecan-1 in all cell layers, except the basal cell layer, whereas endocervical columnar epithelium stained weakly. In non-neoplastic reactive lesions, metaplastic squamous cells were positive for syndecan-1, whereas columnar cells showed weak or negative staining. In cervical condylomas, cells showing koilocytotic atypia were positive for syndecan-1. The progression of cervical intraepithelial neoplasia (CIN) grade I to grade III was associated with reduced syndecan-1 expression and localization of syndecan-1 to more superficial cell layers. In squamous cell carcinomas (SCCs), syndecan-1 expression correlated with histological differentiation, being absent from most poorly differentiated tumours. The results suggest that loss of syndecan-1 from atypical cells is an early event during cervical carcinogenesis and show a close association of syndecan-1 expression with preserved epithelial morphology and differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207616     DOI: 10.1002/path.1711720410

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.

Authors:  S V Litvinov; W van Driel; C M van Rhijn; H A Bakker; H van Krieken; G J Fleuren; S O Warnaar
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Heparan sulfate signaling in cancer.

Authors:  Erik H Knelson; Jasmine C Nee; Gerard C Blobe
Journal:  Trends Biochem Sci       Date:  2014-04-19       Impact factor: 13.807

3.  Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia.

Authors:  Gábor Sobel; István Szabó; Csilla Páska; András Kiss; Ilona Kovalszky; Anna Kádár; Ferenc Paulin; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

4.  Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway.

Authors:  Haiguo Sun; Yunping Hu; Zhennan Gu; Rick T Owens; Yong Q Chen; Iris J Edwards
Journal:  Carcinogenesis       Date:  2011-07-18       Impact factor: 4.944

Review 5.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Syndecan-1 - A new piece in B-cell puzzle.

Authors:  L Kopper; A Sebestyén; M Gallai; I Kovalszky
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

7.  Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.

Authors:  Haiguo Sun; Isabelle M Berquin; Rick T Owens; Joseph T O'Flaherty; Iris J Edwards
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells.

Authors:  J P van Putten; S M Paul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

9.  Syndecan expressions in the human amnion and chorionic plate.

Authors:  T Lorenzi; A Turi; C Crescimanno; M Morroni; M Castellucci; G David; A L Tranquilli; D Marzioni
Journal:  Eur J Histochem       Date:  2010-10-27       Impact factor: 3.188

10.  Prognostic significance of syndecan-1 expression in cervical cancers.

Authors:  Yu Im Kim; Ahwon Lee; Bum Hee Lee; Su Young Kim
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.